What We Do
Quantum Fusion designs and manufactures innovative nano biomaterials and advanced formulations that integrate seamlessly with AI-assisted health technologies for predictive diagnostics, personalised nutrition, and preventive medicine.
Our research and development programmes focus on creating highly characterised nano-enabled ingredients for applications in:
- AI-assisted predictive health and preventive medicine
- Neurodevelopmental disorders
- Neurodegenerative disorders
- Antimicrobial resistance
- Critical and intensive care support
- Renal and kidney health
- Cardiac and vascular health
- Liver health and metabolic wellness
- Gut–brain and liver–brain axis modulation
- Mental health and cognitive performance
- Sleep optimisation
- Healthy ageing and longevity
- Human performance in extreme environments, including future space missions
Our Technology Platform
At Quantum Fusion, we engineer functional nanobiomaterials using advanced synthesis, purification, and characterisation technologies which includes:
- Ultra-small nanobiomaterials (<10 nm)
- Functional nanoparticles (10–50 nm)
- Nano-enabled nutraceuticals
- Nano food ingredients
- Quantum nutritional supplements
- Precision nanodelivery systems
- AI-enabled biomarker integration for predictive health applications
Every innovation is developed with the objective of improving biological performance while maintaining high standards of quality, reproducibility, and scientific validation.
Innovation Through Science
Our multidisciplinary team combines expertise in nanotechnology, materials science, biology, medicine, artificial intelligence, engineering, and data science to translate cutting-edge research into practical healthcare solutions.
We collaborate with researchers, clinicians, academic institutions, healthcare organisations, and industry partners to accelerate innovation from laboratory discovery to real-world impact.
Our development philosophy combines:
- Scientific excellence
- Responsible innovation
- Evidence-based product development
- Advanced manufacturing
- Global quality standards
Our Vision & Mission
Our Vision
To become a global leader in nano-enabled health technologies by transforming preventive healthcare through intelligent nanomaterials, precision nutrition, and AI-driven predictive medicine.
Our Mission
To develop safe, innovative, and scientifically validated nano-enabled products that empower individuals to live healthier, longer, and more productive lives while addressing some of the world’s most significant healthcare challenges.
Looking Ahead
Quantum Fusion is committed to building the future of healthcare—where nanotechnology, artificial intelligence, and precision biology work together to enable earlier prediction, better prevention, more effective intervention, and healthier ageing.
By continuously advancing nano-enabled science and translating breakthrough research into practical solutions, we aspire to improve the quality of life for people across the globe and contribute to a healthier future for generations to come.
Leadership Team
Meet the visionaries behind Quantum Fusion's revolutionary approach
Dr. Kaviarasu Balakrishnan
Dr. Kaviarasu Balakrishnan is the Founder & President of the Dr. Krishnamoorthy Foundation for Advanced Scientific Research in Vellore, India. Founder & Director at Kattam Intelligence, Singapore. He has a background in engineering with a PhD in Nanorobotics and is also experienced in Siddha, Ayurveda and Unani medicine. He has developed drug therapies for various neurodevelopmental disorders and created an AI based Software as a Medical Device (SaMD) for predictive diagnosis at birth. His work spans multiple sectors, focusing on Mental health, Neurology, Endocrinology and holistic wellness.
RB Sreenivasan
Co founder & Director at Quantum Fusion, he is also the co founder and director at Kattam Intelligence Pte. Ltd., Singapore. An Artificial Intelligence based Software as a Medical Device (SaMD) predictive health diagnostics company. He holds the position of Vice-President at Dr. Krishnamoorthy Foundation for Advanced Scientific Research, Vellore, India. He has a background in engineering with a masters in business administration.
Parameswaran Muniandy
He is the Resident director at Quantum Fusion, he is also the resident director at Kattam Intelligence Pte. Ltd., Singapore. An Artificial Intelligence based health diagnostics company.
Dr. Surendra B. Gadamsetty
Dr. Surendra B. Gadamsetty is a biopharmaceutical innovator and entrepreneur, and a Principal Scientist at Merck Research Laboratories. He earned his PhD from RWTH Aachen University, Germany, with doctoral research at UC San Diego, USA. He has authored 20 publications and holds patents in drug discovery.
Global Presence
Serving customers worldwide with excellence and innovation
Singapore Headquarters
Our main office in Singapore serves as the hub for research, development, and global operations, leveraging the city-state's advanced infrastructure and strategic location.
India Manufacturing
Quantf Bharat Pvt. Ltd. in India provides state-of-the-art manufacturing capabilities, ensuring high-quality production and supply chain efficiency.
Global Distribution
Our products reach customers across multiple continents through a robust distribution network, bringing quantum-enhanced health solutions to people worldwide.
Research Partnerships
Collaborating with leading institutions to advance healthcare innovation
Vellore Institute of Technology
Premier engineering and technology institute driving innovation in nanotechnology research.
Sathyabama University
Leading institution in biotechnology and pharmaceutical research for novel formulations.
Tamil Nadu Agricultural University
Agricultural research institution focusing on natural compounds and botanical extracts.
Annamalai University
University with expertise in pharmaceutical sciences and natural product research.